Press Coverage of Littlepage Booth
Rainey Booth in the Rezulin deposition of Warner Lambert rep J. Wright Witcher, describing how the company misled and manipulated physicians
Littlepage & Booth's continuing battles against giant drug companies on behalf of our clients has gained national press attention. From a firm profile in the Texas Lawyer, the state's most widely read news source for attorneys, to coverage of our clients' stories by the New York Times and the CBS News with Dan Rather, our important work is covered throughout the country.
Littlepage & Booth is one of the few law firms in the nation to focus exclusively on defective medical products and drug cases such as Prempro. Littlepage & Booth has tried three of the six Pfizer Rezulin cases to reach trial in the nation returning over 37 million dollars in verdicts in the year 2002.
Read about Littlepage & Booth and our clients as reported by:
- CBS News
- Reno Gazette Journal
- NPR/Sky Radio
- Network Television
- Passion Beyond ABC's 'The Practice' (PDF)
- The Practice
- CBS Evening News - "Did Rezulin Maker Deceive Doctors ...."
- CBS Evening News - "Diabetes Drug On Trial"
- Texas Lawyer
- New York Times
- Los Angeles Times
- Omaha World Herald
- National Law Journal
- Mealey's Litigation Report
- 1st Class Action Suit Following Ancure Guilty Pleas Is Filed - Emerging Drugs and Devices (external)
- Judge Cuts Fee Award By $6.3 Million - Fen-Phen/Redux (external)
- Mistrial Declared After Juror Sees Plaintiff Collapse - Diabetes Drugs (external)
- State Of Illinois Bans Sale Of Ephedra Products - Ephedra & PPA (external)
- Baycol Defendants Seeking Order Requiring Case-Specific Reports - Baycol (external)
- 8th Circuit Rules Trial Court Did Not Err In Kennedy Latex Case Rulings (external)
- Defendants Argue All Vaccine-Related Claims Belong In Vaccine Court - Thimerosal & Vaccines (external)
- Jury Meant To Award Plaintiffs $26.2 Million
- Bloomberg News
- Climate Business Magazine
- Washington Post
- San Antonio Express-News
- Press Release